Perrigo Company Public Limited Company

Healthcare
$30.80
+0.86(2.87%) 1D
1D
1W
1M
1Y
3Y
5Y

Performance

Open PricePrev. CloseVolumeAvg. Volume
$29.92$29.941,168,2191,668,886

Fundamentals

Market Cap$4.17B
P/B Ratio0.9
P/E Ratio-328.7
Enterprise Value$7.49B
Div. Yield3.69%
Book Value34.97
EPS(TTM)0.10
ROENA
Understand Fundamentals

About the Company

Perrigo Company plc, commonly referred to as Perrigo, is a private label over-the-counter pharmaceuticals manufacturing company. The company has two headquarters located in Dublin, Ireland and Allegan, USA. As of 2020, it has an employee base of over 11,100 individuals working on more than 3,000 product formulations. Other than its two headquarters, it also has an office operating in Portugal. It operates under three segments, namely Rx Pharmaceuticals, Consumer Self-Care Americas and Consumer Self-Care International. It has stock-keeping units of more than 14,000, and it offers products under several categories, such as Nutrition, Pain and Sleep-Aids, Oral Self-Care, Healthy Lifestyle, Prescription, Skincare and Personal Hygiene, Digestive Health and Vitamins, Minerals and Supplements. Some of its products that are marketed in North America are clearlax, Advantage, mucus.DM, personal lubricant, acid reducer, aspirin, naproxen sodium, etc. Its notable European products are Panodil 500, NiOuitin, Nytol, bronchostop, Phytosun aroms, Plackers, XL.S Medical, Coldrex, etc. The company also has a subsidiary named Omega Pharma. This company was founded in 1887 by two general store owners named Charles and Luther Perrigo as the L. Perrigo Company. By 1991, Perrigo Corporation had an initial public offering (IPO) on the NASDAQ stock exchange. However, as of 2021, Perrigo shares trade on the New York Stock Exchange (NYSE) and Tel Aviv Stock Exchange(TASE) under the ticker symbol PRGO. It is also a component of the S&P 500 index. Over the years, it has acquired several companies, and its first significant acquisition was Agis Industries Limited, a generic pharmaceuticals company, in 2005. It took over four companies in 2008; these were JB Laboratories, Unico Holdings, Galpharm International and Laboratories Diba SA. In 2010, it acquired PBM Holdings Inc. and Orion Laboratories Pty Ltd. From 2011 to 2016, Perrigo acquired seven companies in total, namely Paddock Laboratories Inc. in 2011, Sergeant’s Pet Care Products Inc. in 2012, Elan and Rosemont Pharmaceuticals Ltd in 2013, Omega Pharma in 2015 and Geiss, Destin & Dunn and Geiss, Proteon Therapeutics in 2016. The company has received several recognitions in the past few years. In 2020, OTC awarded it the title of “OTC Company of the Year”. Forbes also recognised it in its 2019 list of America’s Best Midsize Employers.;
OrganisationPerrigo Company Public Limited Company
IndustryDrug Manufacturers—Specialty & Generic
HeadQuartersDublin

Company Financials

*All values are in Million $
No Graph Data To Display
Quarterly
Yearly

Similar Stocks

COMPANYMARKET PRICECLOSE PRICEMARKET CAP
Invest the way you want
Join millions of Indians who trust and love Groww
Explore Products
ⓒ 2016-2024 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 4.8.7
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  IDFC |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ